Fresenius Medical Care KGAA ST (FMEG)

Currency in EUR
42.205
+0.365(+0.87%)
Real-time Data·
Advertisement
FMEG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
41.93542.265
52 wk Range
34.57047.860
Key Statistics
Prev. Close
41.84
Open
41.935
Day's Range
41.935-42.265
52 wk Range
34.57-47.86
Volume
43.98K
Average Volume (3m)
876.5K
1-Year Change
-10.0873%
Book Value / Share
48.99
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
FMEG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
43.694
Upside
+3.53%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

5 Buy
6 Hold
5 Sell
Ratings:
16 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 43.694
(+3.53% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Morgan Stanley
Buy48.00+13.73%56.00Maintain23/06/2026
Deutsche Bank
Buy55.00+30.32%57.00Maintain08/05/2026
Barclays
Buy56.50+33.87%57.00Maintain07/05/2026
Citi
Buy53.00+25.58%57.00Maintain24/04/2026
UBS
Buy54.00+27.95%57.00Maintain23/04/2026

Earnings

Latest Release
05/05/2026
EPS / Forecast
0.91 / 0.97
Revenue / Forecast
4.61B / 4.66B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 3.29%
Dividend Yield
3.56%
Industry Median 2.30%
Annualised payout
1.49
Paid annually
5-Years Growth
+2.14%
Growth Streak

Compare FMEG to Peers and Sector

Metrics to compare
FMEG
Peers
Sector
Relationship
P/E Ratio
11.9x18.8x−0.4x
PEG Ratio
0.210.230.00
Price/Book
0.8x1.5x2.6x
Price / LTM Sales
0.6x1.6x3.0x
Upside (Analyst Target)
−0.8%52.8%51.9%
Fair Value Upside
Unlock15.2%9.1%Unlock

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Employees
108165
Market
Germany

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
111.33M41.45%4.68B
Other Institutional Investors
106.61M39.70%4.48B
Public Companies & Retail Investors
50.63M18.85%2.13B
Total
268.56M100.00%11.28B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Fresenius SE & Co. KGaA31.20%83,780,3823,518,776
Dodge & Cox6.15%16,512,790693,537

People Also Watch

77.685
BEIG
+1.26%
72.400
G24n
-0.75%
20.12
UMI
+0.50%
30.100
AFXG
+2.80%
402.7
COLOb
+0.55%

FAQ

What Is the Fresenius Medical Care (Xetra: FMEG) Share Price Today?

The Fresenius Medical Care stock price today is 42.205 EUR.

What Stock Exchange Does Fresenius Medical Care (FMEG) Trade On?

Fresenius Medical Care is listed and trades on the Frankfurt Stock Exchange.

What Is the Ticker (Stock Symbol) for Fresenius Medical Care?

The stock symbol (also called a 'ticker') for Fresenius Medical Care is "FMEG."

Does Fresenius Medical Care Pay Dividends? What’s The Current FMEG Dividend Yield?

Yes, FMEG Pays Dividends to its Shareholders. The current Fresenius Medical Care dividend yield is 3.55%.

What Is the Current Fresenius Medical Care Market Capitalisation?

As of today, Fresenius Medical Care (Xetra: FMEG) market cap is 11.200B EUR.

What Is Fresenius Medical Care's (FMEG) Earnings Per Share (TTM)?

The Fresenius Medical Care EPS is currently 3.294 (Trailing Twelve Months).

When Is the Next Fresenius Medical Care Earnings Date?

Fresenius Medical Care's next earnings report will be released on 04/08/2026.

Is FMEG a Buy or Sell From a Technical Analyst Perspective?

Based on today's Fresenius Medical Care moving averages and other technical indicators, the daily buy/sell signal for FMEG stock is Strong Buy.

How Many Times Has Fresenius Medical Care Stock Split?

Fresenius Medical Care has split 2 times. (See the FMEG stock split history page for full effective split date and price information.)

How Many Employees Does Fresenius Medical Care Have?

Fresenius Medical Care has 108165 employees, based on their latest Companies House report.

What is the current trading status of Fresenius Medical Care (Xetra: FMEG)?

As of 10/07/2026, Fresenius Medical Care (FMEG) is trading at a share price of 42.205 EUR, with a previous close of 41.840 EUR. The stock has fluctuated within a day range of 41.935 EUR to 42.265 EUR, while its 52-week range spans from 34.570 EUR to 47.860 EUR.

What Is Fresenius Medical Care (FMEG) Price Target According to Analysts?

The average 12-month price target for Fresenius Medical Care is 43.694 EUR, with a high estimate of 67 EUR and a low estimate of 31 EUR. 5 analysts recommend buying the stock, while 5 suggest selling, leading to an overall rating of Neutral. The stock has an +3.53% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.